|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01177 SINO BIOPHARM
Nominal 
3.470 -0.060 (-1.700%) Ranking Overview
Ranking based on 5 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 12.59 RMB (cts) | |
| Net Profit | 2,331.94 RMB (MIL) | DPS | 4.53 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 3,755.00 | 19.90 | 6.47 | -- | 4,372.00 | 2,581.00 |
| 2025 | 2,869.00 | 15.49 | 5.07 | -- | 3,170.00 | 2,483.00 |
| 2026 | 3,187.00 | 17.00 | 5.87 | -- | 3,570.00 | 2,843.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 3,881.00 | 21.00 | -- | CITIGROUP | Buy | 7.00 | 31/10/2024 | |
| 2024 | 2,649.00 | 14.00 | 7.56 | UBS | Buy | 5.00 | 20/11/2024 | |
| 2024 | 3,755.00 | 19.90 | 4.60 | BANK OF AMERICA | Buy | 4.00 | 17/02/2025 | |
| 2024 | 4,372.00 | 23.00 | 8.00 | HSBC | Buy | 3.80 | 27/01/2025 | |
| 2024 | 2,581.00 | 13.93 | 5.38 | FIRST SHANGHAI SEC | Buy | 3.79 | 20/09/2024 | |
| 2025 | 3,170.00 | 17.10 | -- | CITIGROUP | -- | -- | 31/10/2024 | |
| 2025 | 2,963.00 | 16.00 | 5.14 | UBS | -- | -- | 20/11/2024 | |
| 2025 | 2,483.00 | 13.20 | 3.00 | BANK OF AMERICA | -- | -- | 17/02/2025 | |
| 2025 | 2,803.00 | 15.00 | 5.00 | HSBC | -- | -- | 27/01/2025 | |
| 2025 | 2,869.00 | 15.49 | 5.98 | FIRST SHANGHAI SEC | -- | -- | 20/09/2024 | |
| 2026 | 3,570.00 | 19.30 | -- | CITIGROUP | -- | -- | 31/10/2024 | |
| 2026 | 3,247.00 | 17.00 | 5.74 | UBS | -- | -- | 20/11/2024 | |
| 2026 | 2,843.00 | 15.10 | 3.50 | BANK OF AMERICA | -- | -- | 17/02/2025 | |
| 2026 | 2,985.00 | 16.00 | 6.00 | HSBC | -- | -- | 27/01/2025 | |
| 2026 | 3,187.00 | 17.20 | 6.57 | FIRST SHANGHAI SEC | -- | -- | 20/09/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 13/03/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,017,162 |
| %Change | 139.689% |
| EPS / (LPS) | RMB 0.164 |
| NBV Per Share (¥) | RMB 1.748 |